CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...